Genentech May Appeal Rejection Of Cabilly Patent
This article was originally published in The Pink Sheet Daily
Executive Summary
U.S. Patent and Trademark Office rejects Genentech’s ’415 patent following Supreme Court ruling permitting MedImmune to challenge its validity.